The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 study of benmelstobart in combination with chemotherapy followed by sequential combination with anlotinib for the first-line treatment of locally advanced or metastatic squamous non-small cell lung cancer (sq-NSCLC).
 
Yuankai Shi
No Relationships to Disclose
 
Longhua Sun
No Relationships to Disclose
 
Runxiang Yang
No Relationships to Disclose
 
Dingzhi Huang
No Relationships to Disclose
 
Yongzhong Luo
No Relationships to Disclose
 
Haichuan SU
No Relationships to Disclose
 
Qiang Liu
No Relationships to Disclose
 
Peng Zhang
No Relationships to Disclose
 
XingYa Li
No Relationships to Disclose
 
Xiangjiao Meng
No Relationships to Disclose
 
Yu Yao
No Relationships to Disclose
 
Lingfeng Min
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose
 
Lei Yang
No Relationships to Disclose
 
Conghua Xie
No Relationships to Disclose
 
Junquan Yang
No Relationships to Disclose
 
Jianhua Shi
No Relationships to Disclose
 
Zhi Xu
No Relationships to Disclose
 
Hongbo Wu
No Relationships to Disclose
 
Honghai Wang
No Relationships to Disclose